Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison ofin vitroandin vivo / ratios for prostate cancer

10 Sept 2004

Abstract excerpt

Parallel in vitro and in vivo studies provide insight into the relationship between clinical response and intrinsic cellular radiosensitivity and may aid in the development of predictive assays. Compilations of radiosensitivity parameters from in vitro experiments can also be used to examine the potential effectiveness of alternative or new treatment plan designs until enough clinical data become available to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Molecular Biology Techniques and Applications
Share to Prostate Cancer Treatment and Research
Share to Statistical Methods in Clinical Trials

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15552412
DOI: 10.1088/0031-9155/49/19/003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison ofin vitroandin vivo / ratios for prostate cancerPMID 15552412Read ↗

Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cellsSemantic proximity Read ↗

Preclinical patient‐derived modeling of castration‐resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient diseaseSemantic proximity Read ↗

RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitizationSemantic proximity Read ↗

PARP Inhibition Sensitizes to Low Dose-Rate Radiation TMPRSS2-ERG Fusion Gene-Expressing and PTEN-Deficient Prostate Cancer CellsSemantic proximity Read ↗

Response of Human Prostate Cancer Cells and Tumors to Combining PARP Inhibition with Ionizing RadiationSemantic proximity Read ↗

Dynamic differences between DNA damage repair responses in primary tumors and cell linesSemantic proximity Read ↗

Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathwaySemantic proximity Read ↗

Fitting the linear–quadratic model to detailed data sets for different dose rangesSemantic proximity Read ↗

Targeted Radiosensitization of ETS Fusion-Positive Prostate Cancer through PARP1 InhibitionSemantic proximity Read ↗

A 4-Gene Signature of CDKN1, FDXR, SESN1 and PCNA Radiation Biomarkers for Prediction of Patient RadiosensitivitySemantic proximity Read ↗

Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer IrradiationSemantic proximity Read ↗

Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.